P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration

We have shown deficits in monocyte phagocytosis from patients with age-related macular degeneration (AMD). Cell membrane fluidity is known to affect phagocytic capacity and leucocyte functionality more generally. Therefore, we examined membrane fluidity of peripheral blood leucocytes in human patients with AMD and in the P2X7 null mouse model of AMD using flow cytometry with a fluorescent probe for fluidity, TMA-DPH. The results showed that membrane fluidity was decreased in all leucocyte types of late AMD relative to healthy controls (HC) including monocytes, neutrophils and lymphocytes but this was not apparent in earlier stages of AMD. Further analysis of factors contributing to membrane fluidity indicated that pre-treatment of monocytes and lymphocytes with ATP greatly increased membrane fluidity in humans and mice. Evidence from P2X7 null mice and P2X7 antagonists confirmed that these ATP-driven increases in membrane fluidity were mediated by P2X7 but were not associated with the classic P2X7 functions of pore formation or phagocytosis. Analysis of P2X7 expression indicated that receptor levels were elevated in classic monocytes of late AMD patients, further suggesting the P2X7 may contribute to altered plasma membrane properties. Our findings identified a novel biological function of P2X7 in modulating membrane fluidity of leucocytes and demonstrated reduced membrane fluidity in cellular changes associated with the late stage of AMD.

Automated summary

This study examined the membrane fluidity of peripheral blood leucocytes in patients with age-related macular degeneration (AMD) and in a mouse model lacking the P2X7 gene. The results showed decreased membrane fluidity in all types of leucocytes in late AMD patients. Pre-treatment with ATP increased membrane fluidity in monocytes and lymphocytes. P2X7 was found to mediate these ATP-driven increases in membrane fluidity, but without affecting pore formation or phagocytosis. The findings suggest a novel biological function of P2X7 in modulating membrane fluidity.